Nantahala Capital Management LLC raised its position in Elutia Inc. (NASDAQ:ELUT - Free Report) by 11.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,184,947 shares of the company's stock after buying an additional 320,000 shares during the quarter. Nantahala Capital Management LLC owned about 7.82% of Elutia worth $8,058,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. OMERS ADMINISTRATION Corp bought a new position in Elutia in the 1st quarter valued at about $28,000. Knollwood Investment Advisory LLC grew its holdings in shares of Elutia by 10.7% during the 1st quarter. Knollwood Investment Advisory LLC now owns 1,034,617 shares of the company's stock valued at $2,618,000 after purchasing an additional 100,000 shares during the last quarter. Perkins Capital Management Inc. grew its holdings in shares of Elutia by 32.1% during the 1st quarter. Perkins Capital Management Inc. now owns 1,136,377 shares of the company's stock valued at $2,875,000 after purchasing an additional 276,300 shares during the last quarter. AIGH Capital Management LLC grew its holdings in shares of Elutia by 10.0% during the 1st quarter. AIGH Capital Management LLC now owns 3,381,415 shares of the company's stock valued at $8,555,000 after purchasing an additional 306,740 shares during the last quarter. Finally, Arcus Capital Partners LLC bought a new stake in shares of Elutia during the 1st quarter valued at approximately $51,000. 74.03% of the stock is owned by institutional investors.
Elutia Trading Down 6.5%
NASDAQ:ELUT traded down $0.13 during mid-day trading on Friday, hitting $1.88. 202,022 shares of the company's stock were exchanged, compared to its average volume of 44,111. The company has a 50 day simple moving average of $2.10 and a 200-day simple moving average of $2.25. Elutia Inc. has a fifty-two week low of $1.61 and a fifty-two week high of $5.12. The firm has a market capitalization of $79.71 million, a P/E ratio of -1.77 and a beta of 0.89.
Elutia (NASDAQ:ELUT - Get Free Report) last posted its earnings results on Thursday, August 14th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.09). The company had revenue of $6.26 million for the quarter, compared to analyst estimates of $6.55 million. As a group, analysts expect that Elutia Inc. will post -1.74 earnings per share for the current year.
Wall Street Analyst Weigh In
Separately, Lake Street Capital decreased their price target on shares of Elutia from $10.00 to $8.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Elutia has a consensus rating of "Buy" and a consensus target price of $8.00.
View Our Latest Stock Analysis on Elutia
About Elutia
(
Free Report)
Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.
See Also

Before you consider Elutia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elutia wasn't on the list.
While Elutia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.